PIONEERING PRECISION IN
|
|
|
|
At Photonic Pharma LLC, we focus on the early phase of drug development - Lead Discovery - using a game-changing technology platform that combines breakthroughs in fluorescent biosensor engineering and fluorescence lifetime detection in living cells. Thus we achieve a dramatic 30-fold increase in the precision of high-throughput screening of small-molecule libraries, with the potential to transform the productivity of pharmaceutical development.
We partner with industrial and academic collaborators, applying our proprietary advancements in structure-based drug-screening technology, to discover novel small-molecule effectors of therapeutically important protein targets. We have assembled a robust and highly integrated network of techniques, concepts, facilities and collaborators to address a wide range of therapeutic goals. |
PHOTONIC PHARMA NEWS:
October 16, 2020
Photonic Pharma LLC is pleased to announce the sixth anniversary of our founding as we begin our seventh year of business. Photonic sends thanks to all those who made this possible.
October 16, 2020
Photonic Pharma LLC is pleased to announce the sixth anniversary of our founding as we begin our seventh year of business. Photonic sends thanks to all those who made this possible.
October 6, 2020
Photonic Pharma LLC is pleased to announce that the USPTO has issued the patent on Photonic Pharma's exclusive living cell biosensor assay technology, "High-throughput, high-precision methods for detecting protein structural changes in living cells." More info
For the full story and other news, please visit our News page.
Photonic Pharma LLC is pleased to announce that the USPTO has issued the patent on Photonic Pharma's exclusive living cell biosensor assay technology, "High-throughput, high-precision methods for detecting protein structural changes in living cells." More info
For the full story and other news, please visit our News page.